Receptor Protein-Tyrosine Kinases

Name
Receptor Protein-Tyrosine Kinases
Accession Number
DBCAT002977
Description

A class of cellular receptors that have an intrinsic PROTEIN-TYROSINE KINASE activity.

Drugs
DrugDrug Description
Nelipepimut-SInvestigated for use/treatment in prostate cancer and breast cancer.
VEGFR2-169VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)).
Drugs & Drug Targets
DrugTargetType
Nelipepimut-SHLA class I histocompatibility antigen, A-2 alpha chaintarget
Nelipepimut-SHLA class I histocompatibility antigen, A-3 alpha chaintarget